A Look At Morgan Stanley (MS) Valuation After Strong Q1 Results And SpaceX IPO Underwriting Role

مورجان ستانلي

Morgan Stanley

MS

0.00

Morgan Stanley (MS) is back in focus after a strong first quarter, with revenue and earnings above analyst expectations. Investor sentiment has been helped by estimate revisions, sector outperformance, and its lead role in the planned SpaceX IPO.

Recent news around strong Q1 results, structured note issuance and a fresh round of preferred dividends has arrived alongside a 90 day share price return of 14.61% and a 1 year total shareholder return of 63.31%. This suggests that momentum has been building over both shorter and longer horizons.

If this kind of performance has you curious about what else is moving, it could be a good time to broaden your search with 20 top founder-led companies

With the stock near US$201 and just 1.1% below the average analyst target, plus an internal intrinsic value estimate that is about 9% richer than today’s price, are you looking at genuine upside or a market that is already pricing in future growth?

Most Popular Narrative: 5.6% Overvalued

The most widely followed narrative currently pegs Morgan Stanley's fair value at about $190.33, which sits below the last close of $201.03 and frames the recent rally against more measured long term expectations.

The ongoing increase in global wealth, combined with the accelerating intergenerational transfer of assets, is boosting demand for comprehensive advisory and wealth management solutions, evidenced by record net new assets and a growing client base, which should drive higher recurring fee-based revenue and long-term earnings growth.

Read the complete narrative. Read the complete narrative.

Curious what earnings, margins and valuation multiple this story needs to justify that fair value gap? The narrative is built on specific growth steps and a defined profit profile, not just a headline P/E. The full breakdown shows how recurring fees, buybacks and a lower future multiple are all wired into that $190.33 figure.

Result: Fair Value of $190.33 (OVERVALUED)

However, this storyline can change quickly if fee pressure from passive products bites harder than expected or if tighter regulations lift costs and squeeze margins.

Another Way To Look At Valuation

The fair value narrative flags Morgan Stanley as about 5.6% overvalued, yet the P/E of 18.1x is far below the US Capital Markets industry at 39.9x and below peers at 26.3x, while only slightly above its 18x fair ratio. This raises the question of whether that represents a valuation cushion or a signal that potential upside is already limited.

To see how those relative valuation gaps could matter for future risk and reward, it is useful to compare them with earnings quality, growth, and capital returns, then consider whether the market could move closer to that fair ratio over time. See what the numbers say about this price — find out in our valuation breakdown.

NYSE:MS P/E Ratio as at May 2026
NYSE:MS P/E Ratio as at May 2026

Next Steps

Mixed messages on value and growth potential so far? Take a closer look at the full picture, including 3 key rewards and 3 important warning signs.

Looking for more investment ideas?

If Morgan Stanley has caught your attention, do not stop here. Broaden your watchlist now so you do not miss other compelling opportunities lining up.

  • Spot potential value plays early by scanning 49 high quality undervalued stocks that combine fundamentals with pricing that may not fully reflect their financial profile.
  • Strengthen your focus on resilience with the 66 resilient stocks with low risk scores and see which companies score well on stability and financial risk measures.
  • Get ahead of the crowd by using the screener containing 21 high quality undiscovered gems to surface lesser known stocks with solid underlying metrics.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.